Tm. Kubiak et al., IMPORTANCE OF THE PROLINE RESIDUE TO THE FUNCTIONAL-ACTIVITY AND METABOLIC STABILITY OF THE NEMATODE FMRFAMIDE-RELATED PEPTIDE, KPNFIRFAMIDE (PF4), Peptides, 17(8), 1996, pp. 1267-1277
PF4 has previously been shown to have potent inhibitory effects on myo
activity of somatic muscle strips from the nematode, Ascaris suum. Thi
s study examined the bioactivity and metabolic stability of position 2
- and position 5-modified analogues of PF4. Although the analogues [Le
u(5)] PF4, [Ala(2)]PF4, [Gly(2)]PF4, [Ala(2),Leu(5)]PF4, and [Gly(2),L
eu(5)]PF4 all had qualitatively similar inhibitory effects on A. suum
somatic muscle strips, their effects were quantitatively distinguishab
le and had the order of potency: PF4 = [Leu(5)] PF4 >> [Ala(2)]PF4 = [
Ala(2),Leu(5)] PF4 >> [Gly(2)] PF4 = [Gly(2),Leu(5)] PF4. Leu(5) for I
le(5) substitutions in PF4 did not alter the activity of this peptide;
however, Gly(2)/Ala(2) for Pro(2) substitutions reduced, but did not
abolish, peptide activity. Peptide stability studies revealed that [Gl
y(2)]PF4(2-7) and -(3-7) and [Ala(2)]PF4(2-7), -(3-7), and -(4-7) frag
ments were generated following exposure to A. suum somatic muscle stri
ps. However, the parent peptide (PF4) was not metabolized and appeared
to be resistant to the sequential cleavages of native aminopeptidases
. Observed analogue metabolism appeared to be due to the activity of r
eleased aminopeptidases as identical fragments were generated by incub
ation in medium that had been exposed to somatic muscle strips and fro
m which the strips had been removed prior to peptide addition. It was
found that the muscle stretching and bath mixing characteristics of th
e tension assay led to more effective release of soluble enzymes from
muscle strips and thus greater peptide degradation. These studies reve
al that Pro(2) in PF4 is not essential for the biological activity of
this peptide; however, it does render the peptide resistant to the act
ions of native nematode aminopeptidases. Copyright (C) 1996 Elsevier S
cience Inc.